NINDS Technology Transfer Office NINDS Technology Transfer Office NINDS Technology Transfer Office
Link to NINDS Home Site NINDS TTO Home Page Link to Neuroscience@NIH TTO Forms
About NINDS TTO
For Investigators
For Industry
Available Collaborations and Licenses
Useful Links

Collaboration Opportunities
NINDS Licensing Opportunities

Ongoing NINDS Clinical Trials


Search Licensing
 
Research and Technology Review
 
Licensing Opportunity  (full list)
 
Genes For Niemann-Pick Type C Disease
 
Institute : National Institute of Neurological Disorders and Stroke (NINDS)
 
Description of Invention :

Niemann-Pick disease is a class of inherited lipid storage diseases. Niemann-Pick Type C disease is an autosomal recessive neurovisceral lipid storage disorder which leads to systemic and neurological abnormalities including ataxia, seizures, and loss of speech. Patients with the disease typically die as children. The biochemical hallmark of Niemann-Pick Type C cells is the abnormal accumulation of unesterified cholesterol in lysosomes, which results in the delayed homeostatic regulation of both uptake and esterification of low density lipoprotein (LDL) cholesterol. Niemann-Pick Type C is characterized by phenotypic variability. The disease appears at random in families that have no history of the disorder, making diagnosis problematic. This invention provides the human gene for Niemann-Pick Type C disease and the nucleic acid sequences corresponding to the human gene for Niemann-Pick Type C disease. Also provided is the mouse homolog of the human gene. The invention could lead to improved diagnosis and the design of therapies for the disease and improved means of detection of carriers of the gene. In addition, this invention may contribute to the understanding and development of treatments for atherosclerosis, a more common disorder associated with cholesterol buildup that involves the accumulation of fatty tissue inside arteries that blocks blood flow, leading to heart disease and stroke. The invention may also lead to additional discoveries concerning how cholesterol is processed in the body.
 
Inventors :

ED Carstea, et al.
 
Patent Status :

US Patent Filing
 
NIH Reference Number:
E-122-1997/3
 
Portfolios :

Central Nervous System -Diagnostics-In Vitro-Other
Gene Based Therapies -Diagnostics
Internal Medicine-Diagnostics
 
For Additional Information Please Contact:
Marlene K. Shinn-Astor JD MS, Office of Technology Transfer
Phone: (301)435-4426 Email: shinnm@mail.nih.gov
 
For Additional Information Regarding Collaboration with the Investigator Please Contact:
Laurie Arrants, Technology Development Administrator
Phone: 301-435-3112 Email: arrantsL@ninds.nih.gov
 
 
Last Updated: 7/20/2006
 
Contact us at nindstto@ninds.nih.gov
NINDS Home   |  NINDS TTO Home  | NeuroScience@NIH  |   Forms
DHHS   |  NIH  | FirstGov  |   Accessibility |   Privacy   | Site Index